Antibe Therapeutics (ATBPF) Earnings Date, Estimates & Call Transcripts → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free ATBPF Stock Alerts $0.22 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueATBPF Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATBPF Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsOn June 10, Nvidia makes its next big moveA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. Antibe Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($0.09)($0.09)($0.09)Q3 20241($0.08)($0.08)($0.08)Q4 20241($0.07)($0.07)($0.07)20243($0.24)($0.24)($0.24)Q1 20251($0.08)($0.08)($0.08)Q2 20251($0.08)($0.08)($0.08)Q3 20251($0.11)($0.11)($0.11)Q4 20251($0.13)($0.13)($0.13)FY 20254($0.40)($0.40)($0.40) Get Antibe Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ATBPF and its competitors with MarketBeat's FREE daily newsletter. Antibe Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/14/2024Q3 2024($0.09)($0.06)+$0.03($0.06)--11/13/2023Q3 2023($0.09)($0.07)+$0.02($0.07)--8/14/2023Q2 2023($0.07)($0.08)($0.01)($0.08)--6/29/2023Q4 2023($0.07)($0.04)+$0.03($0.04)--2/14/2023Q3 2023($0.09)($0.06)+$0.03($0.06)--11/14/2022Q2 2023-($0.09)($0.09)($0.09)-- Get the Latest News and Ratings for ATBPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q1 2023($0.09)($0.08)+$0.01($0.08)--2/14/2022Q3 2022($0.13)($0.08)+$0.05($0.09)--11/16/2021Q3 2021($0.11)($0.13)($0.02)($0.13)$2.30 million$2.19 million8/16/2021Q1 2022-($0.11)($0.11)($0.11)-$2.22 million6/28/2021Q4 2021($0.05)($0.11)($0.06)($0.11)$8.80 million$2.33 million2/12/2021Q3 2021($0.09)($0.12)($0.03)($0.11)$2.00 million$2.14 million11/13/2020Q2 2021-($0.02)($0.02)($0.02)-$2.15 million8/24/2020Q1 2021-($0.01)($0.01)($0.01)-$0.89 million7/24/2020Q4 2020-($0.02)($0.02)($0.02)-$1.75 million2/24/2020Q3 2020-($0.01)($0.01)($0.01)-$1.98 million11/28/2019Q2 2020-($0.02)($0.02)($0.02)-$1.72 million8/27/2019Q1 2020-($0.01)($0.01)($0.01)-$2.07 million7/16/2019Q4 2019-($0.02)($0.02)($0.02)-$1.83 million Antibe Therapeutics Earnings - Frequently Asked Questions How much profit does Antibe Therapeutics generate each year? Antibe Therapeutics (OTCMKTS:ATBPF) has a recorded net income of -$14.73 million. ATBPF has generated -$0.25 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: LianBio Earnings Cocrystal Pharma Earnings iBio Earnings AIM ImmunoTech Earnings BioRestorative Therapies Earnings Emmaus Life Sciences Earnings Processa Pharmaceuticals Earnings NovaBay Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Hormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China? This page (OTCMKTS:ATBPF) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Antibe Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
